BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27025619)

  • 1. Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review.
    McFarland LV
    Antibiotics (Basel); 2015 Apr; 4(2):160-78. PubMed ID: 27025619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
    McFarland LV; Ship N; Auclair J; Millette M
    J Hosp Infect; 2018 Aug; 99(4):443-452. PubMed ID: 29702133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics for prevention and treatment of diarrhea.
    Guandalini S
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is primary prevention of Clostridium difficile infection possible with specific probiotics?
    Johnson S; Maziade PJ; McFarland LV; Trick W; Donskey C; Currie B; Low DE; Goldstein EJ
    Int J Infect Dis; 2012 Nov; 16(11):e786-92. PubMed ID: 22863358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics and prevention of Clostridium difficile infection.
    Goldstein EJC; Johnson SJ; Maziade PJ; Evans CT; Sniffen JC; Millette M; McFarland LV
    Anaerobe; 2017 Jun; 45():114-119. PubMed ID: 27988389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
    Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
    Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections.
    McFarland LV
    Benef Microbes; 2015; 6(2):189-94. PubMed ID: 24889895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanisms and safety of probiotics against toxigenic
    Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Jul; 41(7):1212-21. PubMed ID: 17595306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
    Maziade PJ; Pereira P; Goldstein EJ
    Clin Infect Dis; 2015 May; 60 Suppl 2():S144-7. PubMed ID: 25922400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
    Auclair J; Frappier M; Millette M
    Clin Infect Dis; 2015 May; 60 Suppl 2():S135-43. PubMed ID: 25922399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
    McFarland LV; Evans CT; Goldstein EJC
    Front Med (Lausanne); 2018; 5():124. PubMed ID: 29868585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis.
    Shen NT; Maw A; Tmanova LL; Pino A; Ancy K; Crawford CV; Simon MS; Evans AT
    Gastroenterology; 2017 Jun; 152(8):1889-1900.e9. PubMed ID: 28192108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis.
    Lau CS; Chamberlain RS
    Int J Gen Med; 2016; 9():27-37. PubMed ID: 26955289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea.
    Katz JA
    J Clin Gastroenterol; 2006 Mar; 40(3):249-55. PubMed ID: 16633131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
    McFarland LV
    Am J Gastroenterol; 2006 Apr; 101(4):812-22. PubMed ID: 16635227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
    Goldenberg JZ; Ma SS; Saxton JD; Martzen MR; Vandvik PO; Thorlund K; Guyatt GH; Johnston BC
    Cochrane Database Syst Rev; 2013 May; (5):CD006095. PubMed ID: 23728658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics for Prevention and Treatment of Clostridium difficile Infection.
    Valdés-Varela L; Gueimonde M; Ruas-Madiedo P
    Adv Exp Med Biol; 2018; 1050():161-176. PubMed ID: 29383669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics for the prevention of antibiotic-associated diarrhoea in older patients: a systematic review.
    Xie C; Li J; Wang K; Li Q; Chen D
    Travel Med Infect Dis; 2015; 13(2):128-34. PubMed ID: 25805164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.